The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
In 2024, the most-read articles published in Population Health, Equity & Outcomes (PHEO) highlighted the promise of ...
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...
Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 ...
Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down the risks of the trend.
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback